XJPX
4427
Market cap13mUSD
Oct 09, Last price
207.00JPY
1D
-2.36%
1Q
11.29%
IPO
-95.33%
Name
EduLab Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
EduLab, Inc. is dedicated to pioneering research and development in academic assessment technologies and innovative educational tools, serving markets both domestically in Japan and internationally. The company delivers a diverse suite of testing and learning services, primarily supporting language-focused educational institutions, including universities, corporate entities, and individual students. Among its specialized offerings are Einavi! and StudyGear, online platforms designed to assist learners in preparing for practical English proficiency tests. EduLab also provides Eiken Jr., an engaging, game-based English learning and assessment program tailored for preschoolers through junior high students. Further contributions include TEAP CBT, a comprehensive English proficiency examination assessing reading, writing, listening, and speaking skills, as well as CASEC, an advanced English assessment system utilizing item response theory and computer-adaptive testing methodologies. The company also develops specific speaking test systems for Eiken grades 4 and 5, alongside support mechanisms for Eiken group enrollments. Headquartered in Tokyo, Japan, EduLab was established in 2015.
Key people
Daisuke Hojo
Vice President, Manager of Business Strategy Office, President & Chief Executive Officer of Subsidiary, Director · since 2019
Masaki Ikeda
Managing Director, Chief Director of Administration · since 2020
Hiroshi Matsuda
Director · since 2021
Nobuhiko Seki
Chief Financial Officer, Director · since 2021
Koji Takahashi
Chief Marketing Officer, Assistant Manager of Strategy Office, Director · since 2019
Junichi Takamura
Director · since 2021
Tatsuya Yasunaga
President & Chief Executive Officer of Subsidiary, Director · since 2019
Yoshitaka Hombo
Independent Director · since 2017
Mitsuhiro Nagata
Independent Director · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑09 | 2024‑09 | 2023‑09 | 2022‑09 | 2021‑09 | 2020‑09 | 2019‑09 | 2018‑09 | 2017‑09 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||